Swolin-Eide, Diana http://orcid.org/0000-0001-9633-6673
Forsander, Gun http://orcid.org/0000-0002-0266-9651
Pundziute Lyckå, Auste http://orcid.org/0000-0001-9731-5559
Novak, Daniel http://orcid.org/0000-0002-7892-7880
Grillari, Johannes http://orcid.org/0000-0001-5474-6332
Diendorfer, Andreas B. http://orcid.org/0000-0003-0331-9685
Hackl, Matthias http://orcid.org/0000-0002-4136-7293
Magnusson, Per http://orcid.org/0000-0002-2123-7838
Funding for this research was provided by:
ALF-grants Gothenburg (ALFGBG-716831, 678871, 965009)
The Swedish Child Diabetes Foundation
Swedish Diabetes Foundation
ALF-grants Region Östergötland
Linköping University
Article History
Received: 15 February 2023
Accepted: 11 July 2023
First Online: 19 July 2023
Competing interests
: Disclosure summary: A.B.D. and M.H. are employed by TAmiRNA GmbH. J.G. and M.H. are shareholders of TAmiRNA and hold IP in relation to the diagnostic use of circulating miRNAs. The other authors do not have any competing interests.